Walleye Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $873K | Sell |
2,639
-3,329
| -56% | -$1.13M | 0.01% | 2201 |
|
|
2025
Q4 | $2.37M | Sell |
5,968
-16,377
| -73% | -$7.25M | 0.01% | 1743 |
|
|
2025
Q3 | $10.2M | Sell |
22,345
-16,370
| -42% | -$6.67M | 0.08% | 541 |
|
|
2025
Q2 | $12.6M | Buy |
38,715
+36,345
| +1,534% | +$10.1M | 0.12% | 406 |
|
|
2025
Q1 | $640K | Sell |
2,370
-17,746
| -88% | -$4.56M | 0.01% | 2350 |
|
|
2024
Q4 | $4.73M | Buy |
20,116
+16,467
| +451% | +$4.33M | 0.05% | 1112 |
|
|
2024
Q3 | $1M | Sell |
3,649
-66,658
| -95% | -$17.4M | 0.01% | 2644 |
|
|
2024
Q2 | $17.1M | Buy |
70,307
+23,449
| +50% | +$3.7M | 0.18% | 433 |
|
|
2024
Q1 | $7M | Buy |
46,858
+22,044
| +89% | +$3.68M | 0.08% | 1067 |
|
|
2023
Q4 | $4.75M | Buy |
+24,814
| New | +$4.23M | 0.07% | 1141 |
|
|
2023
Q3 | – | Sell |
-1,040
| Closed | -$198K | – | 4848 |
|
|
2023
Q2 | $198K | Buy |
+1,040
| New | +$206K | ﹤0.01% | 3091 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3908 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3153 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3211 |
|
|
2022
Q1 | – | Sell |
-3,772
| Closed | -$640K | – | 2262 |
|
|
2021
Q4 | $640K | Buy |
3,772
+104
| +3% | +$19.3K | 0.02% | 841 |
|
|
2021
Q3 | $693 | Buy |
+3,668
| New | +$688K | 0.02% | 634 |
|
|
2020
Q1 | – | Sell |
-1,870
| Closed | -$215K | – | 881 |
|
|
2019
Q4 | $215K | Buy |
+1,870
| New | +$186K | 0.05% | 1075 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1875 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1705 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1482 |
|
|
2018
Q3 | $751K | Buy |
+8,585
| New | +$864K | 0.41% | 81 |
|
Other funds holding ALNY
VPM
VCM
